PATTERNS OF PSYCHOPHARMACOLOGIC TREATMENT FOR ADHD

ADHD 的心理药物治疗模式

• 批准号: 2773651
• 负责人: Susan C dosReis
• 金额: $ 2.21万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2773651
• 关键词: Medicare /Medicaid; adolescence (12-20); attention deficit disorder; attitude; child (0-11); child mental health service; clinical research; health care facility information system; health care professional practice; health care referral /consultation; health care service evaluation; health services research tag; human data; human therapy evaluation; managed care; mental disorder chemotherapy; outcomes research; satisfaction; socioeconomics

An increase in methylphenidate (Ritalin/R) prescriptions for the treatment of attenuation deficit hyperactivity disorder (ADHD) is being observed yet knowledge of the extent and variety of pharmacotherapy and behavioral treatments is limited and only regional. The primary goal of this study is to provide clinicians, researchers, and consumers with information on psychopharmacologic practices for ADHD. The specific aims of the study are three-fold: to compare ADHD treatment patterns for HMO child members with ADHD treatment patterns for Medicaid child members; to describe the referral patterns for ADHD treatment among a sample of school-aged children; to survey parents' knowledge, attitude, and satisfaction with their child's ADHD treatment. The analytic plan includes multivariate statistical models such as logistic regression log- linear regression, and multiple regression. The study is designed to examine socioeconomic and practice setting differences in medication treatment patters for ADHD and to identify areas of the child's clinical treatment that warrant further attention. The finds will provide important information on how children in need of behavioral health services access treatment and will describe parental satisfaction with the result of medication treatment. A clear understanding of the parents' perspective regarding their child's treatment is relevant to the continuity of care for children, which can be related to the long-term effectiveness of treatment for ADHD. The findings are important for clinical management and improvement of care for children with ADHD. The benefits, from a public health perspective, include the opportunity to examine psychopharmacologic treatment patterns for youth with regard to access, patient education, and satisfaction with the provision of care. Knowledge of practice trends for ADHD therapy is useful for a fundamental understanding of pediatric psychopharmacologic practices in general. The instrument used to assess treatment may lead to future development of an ADHD treatment monitoring protocol for outcome studies of long-term treatment effectiveness.

用于治疗的哌甲酸甲酯(利他林/R)处方增加 衰减性多动障碍(ADHD)的研究尚在进行中 了解药物治疗和行为疗法的范围和种类 治疗是有限的，而且只是地区性的。这项研究的主要目标是 为临床医生、研究人员和消费者提供有关 ADHD的精神药理学实践。 这项研究的具体目的有三个：比较ADHD的治疗 HMO儿童成员的ADHD医疗补助治疗模式 儿童成员；描述以下人群中ADHD治疗的转诊模式 对学龄儿童的抽样调查；调查父母的知识、态度、 对孩子的多动症治疗感到满意。分析计划 包括多元统计模型，如Logistic回归对数 线性回归和多元回归。 这项研究旨在考察社会经济和实践环境。 ADHD的药物治疗模式的差异及识别领域 儿童的临床治疗情况值得进一步关注。这个 FINDS将提供有关有需要的儿童如何 行为健康服务获得治疗，并将描述父母 对药物治疗结果的满意度。一目了然 理解父母对孩子的看法 治疗与儿童护理的连续性有关，这可能是 与ADHD治疗的远期疗效有关。 这些发现对临床管理和改善护理具有重要意义。 适用于患有多动症的儿童。从公共卫生的角度来看， 包括检查精神药物治疗模式的机会 对于年轻人来说，在获得机会、耐心教育和对 提供护理服务。对ADHD治疗实践趋势的了解是 有助于对儿科精神药理学的基本了解 一般的做法。用于评估治疗的工具可能会导致 ADHD治疗结果监测方案的未来发展 长期治疗效果的研究。